Cortés-Ramírez DA, Rodríguez-Tojo MJ, Coca-Meneses JC, Marichalar-Mendia X, Aguirre-Urizar JM. Epidermal growth factor receptor expression in different subtypes of oral lichenoid disease. Med Oral Patol Oral Cir Bucal. 2014 Sep 1;19 (5):e451-8.

doi:10.4317/medoral.19452

http://dx.doi.org/doi:10.4317/medoral.19452

1. Aguirre-Urizar JM. Letter to the editor: oral lichenoid disease. A new classification proposal. Med Oral Patol Oral Cir Bucal. 2008;13:e224.

2. van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003;32:507-12.
http://dx.doi.org/10.1034/j.1600-0714.2003.00125.x

3. Cortes-Ramirez DA, Gainza-Cirauqui ML, Echebarria-Goikouria MA, Aguirre-Urizar JM. Oral lichenoid disease as a premalignant condition: the controversies and the unknown. Med Oral Patol Oral Cir Bucal. 2009;14:e118-22.

4. van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal. 2009;14:e310-4.

5. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V. Oral lichen planus: clinical features and management. Oral Dis. 2005;11:338-49.
http://dx.doi.org/10.1111/j.1601-0825.2005.01142.x

6. van der Meij EH, Reibel J, Slootweg PJ, van der Wal JE, de Jong WF, van der Waal I. Interobserver and intraobserver variability in the histologic assessment of oral lichen planus. J Oral Pathol Med. 1999;28:274-7.
http://dx.doi.org/10.1111/j.1600-0714.1999.tb02038.x

7. van der Meij EH, Schepman KP, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:164-71.
http://dx.doi.org/10.1016/S1079-2104(03)00305-6

8. van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 2007;43:742-8.
http://dx.doi.org/10.1016/j.oraloncology.2006.09.006

9. González-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008;14:229-43.
http://dx.doi.org/10.1111/j.1601-0825.2008.01441.x

10. Bombeccari GP, Guzzi G, Tettamanti M, Gianni AB, Baj A, Pallotti F, et al. Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:328-34.
http://dx.doi.org/10.1016/j.tripleo.2011.04.009

11. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317-23.
http://dx.doi.org/10.1016/j.oraloncology.2008.05.016

12. Thornhill MH, Sankar V, Xu XJ, Barrett AW, High AS, Odell EW, et al. The role of histopathological characteristics in distinguishing amalgam-associated oral lichenoid reactions and oral lichen planus. J Oral Pathol Med. 2006;35:233-40.
http://dx.doi.org/10.1111/j.1600-0714.2006.00406.x

13. Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 1994;54:3153-9.

14. Rubin Grandis J, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 1996;78:1284-92.
http://dx.doi.org/10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X

15. Grandis JR. Prognostic biomarkers in head and neck cancer. Clin Cancer Res. 2006;12:5005-6.
http://dx.doi.org/10.1158/1078-0432.CCR-06-1356

16. Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol. 2006;24:2666-72.
http://dx.doi.org/10.1200/JCO.2005.04.8306

17. Srinivasan M, Jewell SD. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology. 2001;61:284-92.
http://dx.doi.org/10.1159/000055335

18. Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, et al. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer. 2008;113:97-107.
http://dx.doi.org/10.1002/cncr.23557

19. Sheikh Ali MA, Gunduz M, Nagatsuka H, Gunduz E, Cengiz B, Fukushima K, et al. Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. Cancer Sci. 2008;99:1589-94.
http://dx.doi.org/10.1111/j.1349-7006.2008.00861.x

20. Ebrahimi M, Boldrup L, Wahlin YB, Coates PJ, Nylander K. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus. Oral Oncol. 2008;44:634-8.
http://dx.doi.org/10.1016/j.oraloncology.2007.08.001

21. Kumagai K, Horikawa T, Gotoh A, Yamane S, Yamada H, Kobayashi H, et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:748-54.
http://dx.doi.org/10.1016/j.tripleo.2010.06.022

22. Taoudi BM, Saintigny P, Thomas SM, El-Naggar AK, Papadimitrakopoulou V, Ren H, et al. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila). 2010;3:800-9.
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0163

23. Soo R, Putti T, Tao Q, Goh BC, Lee KH, Kwok-Seng L, et al. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Arch Otolaryngol Head Neck Surg. 2005;131:147-52.
http://dx.doi.org/10.1001/archotol.131.2.147

24. Morgan S, Grandis JR. ErbB receptors in the biology and pathology of the aerodigestive tract. Exp Cell Res. 2009;315:572-82.
http://dx.doi.org/10.1016/j.yexcr.2008.08.009

25. Grandis JR, Sok JC. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther. 2004;102:37-46.
http://dx.doi.org/10.1016/j.pharmthera.2004.01.002

26. Prado SM, Cedrun JL, Rey RL, Villaamil VM, García AA, Ayerbes MV, et al. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias. Exp Mol Pathol. 2010;89:197-203.
http://dx.doi.org/10.1016/j.yexmp.2010.06.004

27. Cortes-Ramirez DA, Rodriguez-Tojo MJ, Gainza-Cirauqui ML, Martinez-Conde R, Aguirre-Urizar JM. Overexpression of cyclooxygenase-2 as a biomarker in different subtypes of the oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:738-43.
http://dx.doi.org/10.1016/j.tripleo.2010.08.005

28. Chaiyarit P, Ma N, Hiraku Y, Pinlaor S, Yongvanit P, Jintakanon D, et al. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci. 2005;96:553-9.
http://dx.doi.org/10.1111/j.1349-7006.2005.00096.x

29. Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, et al. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res. 2006;12:5064-73.
http://dx.doi.org/10.1158/1078-0432.CCR-06-0913